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There are two major and alternative pathways to repair DNA double-strand breaks:
non-homologous end-joining and homologous recombination. Here we identify and
characterize novel factors involved in choosing between these pathways; in this study we
took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by
homology-independent or -dependent mechanisms is distinguished by the accumulation of
green or red ﬂuorescence, respectively. Using a genome-wide human esiRNA (endor-
ibonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-
joining ratio. Here we report that two distinct sets of genes are involved in the control of the
balance between NHEJ and HR: those that are required to facilitate recombination and those
that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits
recombination by limiting the initiation and the extent of DNA end resection, thereby acting
as an antagonist of CtIP.
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D
NA double-strand breaks (DSBs) are the most dangerous
form of DNA damage. Unrepaired breaks lead to cell
death, while improperly repaired breaks cause an increase
in genomic instability and, in humans, diseases such as cancer
and premature aging1,2. There are two major pathways to repair
DSBs: non-homologous end-joining (NHEJ) and homologous
recombination (HR)3–5. NHEJ consists of a ligation of two DNA
ends without using homology5. In HR, a homologous sequence is
used as an information donor in a highly regulated mechanism3.
Several recombination subpathways have been described, each
one with distinct outcomes and consequences3. The choice
between these two repair mechanisms is highly regulated, and
changes in the ratio between them can increase genomic
instability4. So far, the best-known regulated step of the DSB
repair pathway choice is the so-called DNA end resection4.
Here strands are degraded 50–30 at each DNA end, giving rise to
ssDNA tails that are immediately coated by the replication
protein A (RPA) complex for protection4. RPA-coated ssDNA is
an obligatory substrate of HR and hampers NHEJ4. A major
player in the choice between NHEJ and HR is CtIP (CtBP
interacting protein), which licenses HR by activating DNA end
resection6. Multiple signals converge on CtIP to initiate DNA end
resection at those breaks that will be repaired by HR4,6,7. In order
to ﬁnd and characterize new factors involved in this crucial
choice, we took advantage of the SeeSaw Reporter (SSR), a system
designed to assess the balance between NHEJ and HR8. Using a
genome-wide human esiRNA library, we found that
downregulation of 1.35% of the genes shifts the NHEJ:HR ratio
towards NHEJ, while depletion of a further 0.71% has the
opposite effect. We focused on CCAR2, which we found to cause
hyper-recombination when depleted. We show that it acts as an
inhibitor of recombination. Speciﬁcally, we found that CCAR2
inhibits initiation and limits the extent of DNA end resection
through its functional interaction with CtIP. This regulation of
DNA end processing modulates the choice between NHEJ and HR.
Results
A genome-wide screening for regulators of the NHEJ:HR ratio.
The SSR2.0 system (Fig. 1a) was designed to calculate the balance
between NHEJ and HR as the ratio of green ﬂuorescent protein
(GFP)-positive versus red ﬂuorescent protein (RFP)-positive cells
of a lone DSB induced by the meganuclease I-SceI (ref. 8).
Note that, in this reporter, mainly a speciﬁc subtype of HR
termed single-strand annealing (SSA) is measured, which is
Rad51-independent and does not require strand invasion3. SSA is
very sensitive to DNA end resection but does not require
additional steps; thus, our screening focused on the early steps
shared by the various HR subpathways. We measured the ratio of
green versus red cells using a high-throughput microscope after
individually downregulating human genes using a genome-wide
esiRNA library (Fig. 1b). We used 96-well plates and included
esiRNA against luciferase in each plate as a control. We discarded
the results of any plate in which the green versus red cell ratio of
the luciferase control varied more than 10% relative to the average
value from all luciferase controls. The ratio of green versus red
cells was calculated for each esiRNA and normalized with the
value of the internal esiRNA against luciferase. The experiment
was repeated independently three times (Supplementary Data 1).
Genes were ranked accordingly to average GFP:RFP cell ratio
normalized with luciferase and represented graphically (Fig. 1c).
We observed three categories of genes with respect to the shape of
the curve. Downregulation of the majority of the genes showed a
NHEJ:HR ratio similar to the control (for example, normalized
GFP:RFP ratio close to 1; dashed black rectangle, Fig. 1c).
Depletion of 0.71% of the genes skewed the balance towards an
increase in HR (for example, normalized GFP:RFP ratio below
0.5; red ellipse, Fig. 1c). As downregulation of those genes
increased HR, we categorize them as genes that naturally favour
NHEJ. An additional 1.35% of the genes favoured HR, that is,
NHEJ increased when downregulated (for example, normalized
GFP:RFP ratio above 3; green ellipse, Fig. 1c). The thresholds
of 0.5 and 3 were established with respect to the inﬂection
points of the curve. Data analyses revealed false-positive
signals for some genes because of a single experiment with
extreme values. To eliminate those, we established the
following criteria (Supplementary Data 2): genes for which
depletion caused an average normalized GFP:RFP ratio below 0.5,
with an individual GFP:RFP normalized ratio below 0.75 for all
three replicas, were included in the category of genes that
favour NHEJ. In contrast, genes for which depletion caused an
average normalized GFP:RFP ratio above 3, with an individual
GFP:RFP normalized ratio above 2 for all three replicas, were
included in the category of genes that favour HR.
Cell cycle is a major regulator of DSB repair pathway choice, as
DNA end resection is limited to the S and G2 phases. Thus, any
genes whose downregulation has an impact on cell cycle
distribution might indirectly affect the NHEJ:HR ratio. To
discard those cases, we used FUCCI-U2OS cells, in which the
cell cycle distribution can be visualized under the microscope
because of the accumulation of cell cycle-controlled
protein fragments fused to ﬂuorescent markers9. We used 358
candidate esiRNAs (Supplementary Data 2) to transfect
FUCCI-U2OS cells. The percentage of G1 cells was determined
by the expression of orange-labelled Cdt1. Cell cycle distribution
was normalized to control cells transfected with esiRNA against
luciferase to obtain a cell cycle correction factor. We then
adjusted the NHEJ:HR ratio according to cell cycle distribution
(Supplementary Data 3). Cell cycle correction had little effect on
the NHEJ:HR ratio in the majority of cases, and only 18 genes
were discarded. In other cases, the corrected ratio was even more
robustly shifted. Thus, after considering cell cycle, we ended up
with a list of 117 genes that favour NHEJ and 223 genes that
favour HR (Supplementary Data 3).
Network analysis. We next analysed these candidate genes in
silico by evaluating whether they were over-represented in certain
functional categories deﬁned automatically using the IPA
software (Ingenuity Systems). Both the genes that favour NHEJ
and those that favour HR were enriched in the functional
categories Cell Cycle and DNA Replication, Recombination and
Repair (Fig. 1d). Moreover, and in agreement with previous
results, RNA metabolism is related to the balance between
HR and NHEJ10 (Fig. 1d). We also found that Cancer-related
genes were over-represented in both sets of genes (Fig. 1d),
validating the relevance of balanced DSB repair for avoiding
tumorigenesis. The Cell Cycle, DNA Repair and Cancer networks
are shown (Fig. 1e).
CCAR2 is a bona ﬁde regulator of DSB repair pathway choice.
The gene for CCAR2 (Cell Cycle and Apoptosis Regulator 2)
was ranked ﬁrst among the candidates that favour NHEJ
(Supplementary Data 3). CCAR2 is also known as DBC1 (Deleted
in Breast Cancer 1) and KIAA1967. We thereafter focused in the
role of CCAR2 in DSB repair pathway choice.
We initially validated the unbalance between HR and NHEJ
using the SSR system in cells depleted of CCAR2 by using
different short interfering RNA (siRNA) and short hairpin RNA
(shRNAs; for CCAR2 depletion, see Supplementary Fig. 1a,b).
CCAR2 downregulation increased HR at the expense of NHEJ
in all cases (Fig. 2a,b). We used the DNA resection gene CtIP
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Figure 1 | A genome-wide screening for factors that control the balance between NHEJ and HR. (a) Schematic representation of the SSR.
An I-SceI-induced DSB can be repaired by NHEJ, thus reconstructing an active GFP gene, or by homologous recombination using RFP fragments,
thus creating a functional RFP gene. (b) Workﬂow of the screening method. Individual esiRNAs deposited in a 96-well plate format were used to
reverse-transfect U2OS cells harbouring a single copy of the SSR system. After 36 h, lentiviral particles bearing I-SceI and the BFP genes were transduced
into cells. After 2 days, cells were imaged using a high-throughput microscope for green, red and blue ﬂuorescence. The number of green and red cells was
then established for each individual esiRNA. Scale bar, 100 mm (c). The ratio between green and red cells was established for each individual esiRNA and
normalized to an internal control (esiRNA targeted against luciferase) that was included in each plate. The individual NHEJ:HR ratio was then ordered and
plotted. Cells with a normalized ratio close to one occupy the central dashed rectangle. Genes for which depletion reduced the ratio (that is, HR was
increased) are marked in the red ellipse and correspond to proteins that naturally favour NHEJ. In contrast, genes that encode pro-recombination proteins
(that is, NHEJ increased when they were downregulated) are included inside the green ellipse. (d) Functional categories enriched among candidates.
The list of candidates that alter the NHEJ:HR ratio was analysed using the IPA Software and categorized into functional groups. Those categories in which
genes were statistically signiﬁcantly over-represented in the set of genes that favour NHEJ (left) or HR (right) are plotted. (e) Network of genes involved in
cell cycle, DNA repair, replication and recombination and cancer, which appear in the set of candidates isolated in the screening. Genes that favour HR are
labelled in green, and those that facilitate NHEJ, in red.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12364 ARTICLE
NATURE COMMUNICATIONS | 7:12364 | DOI: 10.1038/ncomms12364 | www.nature.com/naturecommunications 3
as a positive control. The shift towards HR with CCAR2
downregulation was not because of a change in cell cycle
distribution (Fig. 2c). As the SSR system measures speciﬁcally the
SSA type of HR8, which does not require strand invasion3, we
tested whether the hyper-recombination observed upon CCAR2
downregulation was speciﬁc for the SSA HR subpathway or
whether it is a general feature. For this, we tested the effect of its
depletion on the reporter DR-GFP, which render cells GFP-
positive if gene conversion has occurred after an I-SceI-induced
DSB but not if the break was repaired by SSA11 (Fig. 2d,e).
CCAR2 also inhibited gene conversion. We conﬁrmed that the
main contribution of CCAR2 in DSB repair balance is to control
HR, as only a mild decrease in NHEJ was observed on the NHEJ
reporter EJ5-GFP12 (Fig. 2f). Thus, CCAR2 is a bona ﬁde general
inhibitor of HR in human cells.
CCAR2 has been shown to control the response to cellular
stress by reducing SIRT1 activity and p53 acetylation13,14.
Thus, one possibility was that CCAR2 depletion caused an
upregulation of SIRT1 activity, leading to an increase in HR. In
that scenario, decrease in SIRT1 should have the opposite effect,
that is, reduce HR. We discarded this hypothesis, as SIRT1
depletion actually increases recombination (Supplementary
Fig. 2). Hence, we conclude that CCAR2 inhibits HR in a
SIRT1-independent manner.
CCAR2 recruitment to sites of DNA damage. Proteins involved
in DSB repair commonly act locally at the vicinity of damaged
DNA. Such activity can be visualized by the local accumulation of
the protein to damaged chromatin. Indeed, CCAR2 changed its
localization when cells were challenged with ionizing radiation,
after which it accumulated at DSBs labelled by the presence
of H2AX phosphorylated at Serine 139 (gH2AX; Fig. 3a).
Recruitment of DNA repair proteins to DNA damage usually
depends on the activation of the DNA damage response. To
understand in more detail CCAR2 retention at broken DNA, we
used inhibitors targeting the two major kinases that trigger
the damage response, ATM and ATR, as well as the poly
ba c
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Figure 2 | CCAR2 depletion leads to hyper-recombination. (a) Cells harbouring a single copy of SSR were transfected with the indicated siRNAs. A
non-target siRNA (siNT) and an siRNA against CtIP were used as negative and positive controls, respectively. The resultant NHEJ:HR ratio was normalized
to control cells and plotted. The average and s.d. of four independent experiments performed in triplicate are shown. Statistical signiﬁcance is marked with
one to three asterisks, as described in the Methods section. (b) Same as a, but with cells infected with lentiviral particles harbouring the indicated shRNAs.
shNT (a non-target shRNA) and shRNA against CtIP were used as negative and positive controls, respectively. (c) Cell cycle distribution of cells after
downregulation of the indicated genes with shRNA. (d) A schematic representation of the HR reporter DR-GFP is shown on the left side. An intramolecular
gene conversion is shown, although it is possible that such reporter engages in an intermolecular recombination event with the sister chromatid, with the
same results. Cells bearing such reporters were transformed with the indicated siRNAs. Further details are as in a. (e) Same as d, except that cells were
transduced with viral particles containing the indicated shRNAs. (f) A schematic representation of the NHEJ reporter EJ5-GFP is shown on the left side.
Cells bearing such a reporter were transformed with the indicated siRNAs. Further details are as in a.
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(ADP-ribose) polymerase (PARP). ATM inhibition completely
abolished CCAR2 recruitment upon exposure to ionizing
radiation, whereas ATR inhibitor only partially reduced CCAR2
accumulation (Fig. 3b). Note that this effect was evident even for
cells that retained some gH2AX despite the ATM inhibition. In
contrast, cells treated with PARP inhibitors behaved as control
cells following radiation.
Only a subset of gH2AX foci colocalized with CCAR2 foci
(Fig. 3a). To monitor CCAR2 recruitment at a higher resolution,
we used a laser microirradiation (Fig. 3c). Using an antibody
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against CCAR2, we observed that indeed it accumulates at sites of
DNA damage in 7% of cells (CCAR2 stripe; Fig. 3c). In contrast,
we observed that damaged chromatin, labelled with gH2AX, was
devoid of CCAR2 in 37% of the cells (CCAR2 antistripe; Fig. 3c).
In the remaining cells (56%), we did not observe any speciﬁc
recruitment pattern; however, we cannot determine for those cells
whether CCAR2 was not mobilized upon DNA damage, whether
the difference between its signal and background was too low to
be distinguished or whether the combination of recruitment and
exclusion on the same laser lines prevent its visualization. We
interpreted such results as showing that CCAR2 is recruited to
DNA damage in a subset of breaks but is actively excluded in
another subset. Other proteins that form both stripes and
so-called antistripes upon laser microirradiation have been
already described10,15,16. We conﬁrmed the existence of
CCAR2 antistripes by repeating the experiment in cells stably
expressing GFP-CCAR2 (Fig. 3d). Treatment of cells with
inhibitors against ATM, ATR or PARP before laser
microirradiation rendered a similar picture as for CCAR2 foci
formation (Fig. 3e). Thus, CCAR2 laser stripes, but not
antistripes, are completely dependent on ATM, partially
dependent on ATR and independent of PARP activity (Fig. 3e).
An interesting hypothesis is that cells that use NHEJ for repair
recruit CCAR2 to inhibit HR, while cells that use HR for
repair exclude CCAR2 from damaged chromatin to allow
recombination to take place. Indeed, CCAR2 immunostaining
appeared to be mutually exclusive with accumulation of the
pro-resection protein CtIP in cells harbouring a GFP-CtIP
construct. Further, more than 50% of cells that accumulated
CtIP showed clear CCAR2 exclusion from damaged chromatin
(Fig. 3c,f). In contrast, the majority of the cells that showed
CCAR2 stripes did not show GFP-CtIP accumulation (Fig. 3c).
We observed colocalization in less than 20% of the cells (Fig. 3f).
Moreover, the formation of CCAR2 antistripes was reduced by
fourfold after CtIP depletion in GFP-CCAR2 cells (Fig. 3d,g). We
conclude that CtIP was recruited and retained to DNA damage
independently of CCAR2, but that CCAR2 antistripes depended
on either CtIP accumulation or CtIP-mediated resection.
DNA resection is constrained to the S and G2 cell cycle phases
because of, among other things, the phosphorylation of CtIP by
cyclin-dependent kinases (CDKs)4,7,17. In order to investigate
whether cell cycle position affected CCAR2 retention at, or
exclusion from, damaged chromatin, we performed laser
microirradiation in cells stained with proliferating cell nuclear
antigen (PCNA), to visualize the DNA damage and cyclin A, to
follow cell cycle progression. Cyclin A accumulates in S and G2
phases. To discriminate between them, we followed the intensity
of the staining with cyclin A, which steadily increases during the
cell cycle, and 40,6-diamidino-2-phenylindole (DAPI), which also
increases as a consequence of DNA replication. Thus, G1 cells
(low cyclin A and low DAPI signal) evolved into G2 (high cyclin
and DAPI signal) going through the S phase (intermediate cyclin
and DAPI signals; Fig. 3h). At early time points, we observed
higher levels of CCAR2 at damaged chromatin as compared with
background (stripes) mainly in G1 and G2 phases but also in the
S phase. In contrast, the average intensity at microirradiated
lesions was below the background levels (antistripe) mostly in the
S phase (Fig. 3h). With time, CCAR2 recruitment became more
obvious in G1 and G2, and some CCAR2 exclusion was observed
in G2 but never in G1 (Fig. 3h). This suggested that CCAR2
exclusion from DSBs was mainly restricted to replicating cells,
with only cells in G1 or G2 able to recruit and retain CCAR2.
CtIP does not form laser stripes in G1 cells6. Thus, we
hypothesized that cells with both CtIP and CCAR2 stripes would
reﬂect only a proportion of G2 cells. Laser microirradiation
causes hundreds of breaks in a given cell. For cells containing
laser lines for both CtIP and CCAR2, we wondered whether both
were recruited to the same locations. Indeed, when we looked
closely at cells with recruitment of both proteins, we observed
that the two signals tended not to colocalize (Fig. 3i); this
probably reﬂects the different mechanisms and/or kinetics of
repair for DSBs created on the same laser track.
Resection is inhibited by CCAR2. CtIP-mediated resection is a
well-known molecular switch that controls the balance between
NHEJ and HR6,7. As our results suggested that CCAR2 might act
as an antagonist of CtIP, we next tested whether CCAR2 regulates
DNA end resection. Downregulation of CCAR2 slightly increased
the number of cells that were positive for RPA foci upon exposure
to ionizing radiation (Fig. 4a). There are two non-exclusive ways
to affect DNA end resection: increasing the number of cells that
initiate resection and increasing the amount of DNA resected at
each speciﬁc break. RPA foci formation is a good measurement of
the former, but it is not sensitive enough to estimate the latter.
Thus, as most S and G2 cells initiate resection, and hence show
RPA foci, it is hard to observe an increase in the number of cells
positive for RPA. To better resolve the increased resection upon
CCAR2 depletion, and to test whether CCAR2 also affected the
length of resection, we used a high-resolution technique to
analyse DNA resection in single molecules in vivo (SMART; see
Methods section Single-molecule analysis of resection tracks for
details)18. In short, it is a modiﬁed DNA-combing protocol in
which ssDNA length is measured on stretched DNA ﬁbres18.
Downregulation of CCAR2 not only affected the number of cells
that resect DNA, but also allowed resection to continue deeper
Figure 3 | Opposite recruitment of CCAR2 and CtIP to damaged chromatin. (a) CCAR2 (red) and the phosphorylated form of H2AX (gH2AX; green)
were immunodetected in cells untreated or exposed to 10Gy of IR. (b) Cells pretreated with inhibitors against ATM (ATMi), ATR (ATRi), PARP (PARPi) or
DMSO as a control were irradiated and used for immunoﬂuorescence against CCAR2 and gH2AX. (c) Cells expressing a GFP–CtIP fusion were
microirradiated. CCAR2 recruitment or exclusion from damaged chromatin was determined with an anti-CCAR2 antibody (magenta). Damaged DNA was
visualized using an antibody against gH2AX (red). CtIP was observed as accumulation of GFP signal. The intensities of the signals of the CCAR2 antibody,
GFP-CtIP and gH2AX were determined by an orthogonal line that crossed the damaged chromatin and plotted. (d) Same as in c, but in cells bearing a
GFP-CCAR2 construct and transfected with siRNA against CtIP or luciferase, as indicated. (e) Same as in c, but cells were pretreated with the mentioned
inhibitors. (f) Percentage of cells with GFP–CtIP recruitment that showed recruitment, exclusion or pan-nuclear staining of CCAR2. The average and s.d.’s of
three independent experiments are shown. Statistical signiﬁcance is marked with one to three asterisks, as described in the Methods section. (g) Number
of CCAR2 antistripes upon depletion of CtIP. Data were normalized with an siLUC. The average and s.d. of three independent experiments are shown.
(h) Cells were harvested at the indicated times after laser microirradiation and stained for PCNA (red), CCAR2 (green), Cyclin A (magenta) or DNA (DAPI;
blue). The nuclear intensity of the DAPI and Cyclin A of individual cells (represented as coloured circles) was measured and plotted to follow cell cycle
progression. The intensity of CCAR2 at damaged chromatin (automatically detected as PCNA stripes) was compared with background levels and plotted in
red (intensity at the laser tracks over background; that is, CCAR2 stripes) or green (intensity at the laser tracks below background; that is, CCAR2
antistripes) according to the legend. Representative images are shown on top. (i) A representative cell with both CtIP (green) and CCAR2 (magenta)
stripes is shown. gH2AX is shown in red. Images merging two or three colours are shown. In all panels, scale bars, 7.5mm.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12364
6 NATURE COMMUNICATIONS | 7:12364 | DOI: 10.1038/ncomms12364 | www.nature.com/naturecommunications
into the chromosomes (Fig. 4b,c). In addition, such hyper-
resection was completely dependent on CtIP (Fig. 4b,c),
genetically placing them in the same pathway. Both SMART
and RPA foci were observed upon exposure to ionizing radiation.
To extend our results, and to link them with the hyper-
recombination phenotype observed using nuclease-induced
DSBs (Fig. 2), we measured the accumulation of RPA at AsiSI-
induced breaks by chromatin immunoprecipitation (ChIP;
Fig. 4d). Some breaks induced by this enzyme are repaired only
by NHEJ, while others are repaired by both NHEJ and HR19.
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Upon CCAR2 downregulation, we saw an increased accumulat-
ion of RPA at two different AsiSI-induced breaks that are
normally repaired by NHEJ and HR (Fig. 4d; DSB-III and DSB-
V) but no effect when we analysed a break that is exclusively
repaired by NHEJ (Fig. 4d; DSB-3). The same was observed using
different distances of the cleavage site (Fig. 4d). Thus, it seems
that CCAR2 limits resection at breaks that are normally resected.
To better understand how this occurs, we tested CtIP recruitment
at those same sites after forming DSBs by AsiSI. We observed an
increase in CtIP recruitment at all the breaks, especially at
distances further away from the actual cleavage site (Fig. 4e).
An interesting idea is that CCAR2 might limit resection
of those breaks to which it is actively recruited in an
ATM-dependent manner. As ATM itself heavily affects DNA
end resection, we could not simply inhibit ATM activity.
However, it has been shown previously that ATM phosphorylates
CCAR2 at threonine 454 (ref. 20). Thus, we measured
resection length at cells depleted of endogenous CCAR2 and
complemented with either wild-type or the T454A mutant.
Expression of the wild-type version of the protein completely
suppressed the hyper-resection observed in cells depleted for
CCAR2 (Fig. 4f). Indeed, as exogenous CCAR2 expression led to
a overexpression of the protein (Supplementary Fig. 1c), the
length of resected DNA in cells harbouring the wild-type gene
was shorter than in control cells, reinforcing the idea that CCAR2
is antagonistic to DNA end resection (Fig. 4f). This was not
observed when the non-phosphorylatable version of the protein
was introduced in the cells, indicating that ATM phosphorylation
is truly essential for the inhibitory role of CCAR2 on end
processing (Fig. 4f). Indeed, although this mutant partially
rescued the resection defect, it was not statistically signiﬁcantly
different from the GFP control (Fig. 4f). Thus, CCAR2 limits the
extent of DNA that is resected in an ATM-dependent manner.
CCAR2 antagonizes CtIP by their physical interaction. To
elucidate how CCAR2 exerts its function, we assessed whether
CCAR2 and CtIP physically interact. We observed such an
interaction using a proximity-ligation assay (PLA; Fig. 5a;
Supplementary Fig. 3a; controls for the speciﬁcity of the
technique are shown in Supplementary Fig. 3b). We wondered
whether the interaction is direct or mediated by BRCA1, as both
CCAR2 and CtIP have been shown to interact with BRCA1
(refs 21,22). Depleting BRCA1 did not change the interaction
between CtIP and CCAR2 (Fig. 5a). In fact, the CCAR2–CtIP
interaction seemed constitutive and did not depend on the
presence of DNA damage (Fig. 5a). To conﬁrm the interaction,
we puriﬁed CtIP from U2OS cells using GFP- and FLAG-tagged
version of the protein. Using mass spectrometry, we identiﬁed
CCAR2 as an interactor of CtIP (see Supplementary Table 1).
We observed such an interaction in cells arrested in G1, S
and G2. Moreover, using total cell extracts, we were able to
co-immunoprecipitate endogenous CCAR2 with GFP-CtIP, both
in the presence and absence of DSBs (Fig. 5b and Supplementary
Fig. 4a). Note that endogenous CtIP was also speciﬁcally immu-
noprecipitated (Fig. 5b, arrow), in agreement with the ability of
CtIP to self-interact23. Furthermore, the reciprocal interaction
was observed when GFP-CCAR2 was used to immunoprecipitate
endogenous CtIP (Fig. 5c and Supplementary Fig. 4b).
Remarkably, only the non-phosphorylated form of CtIP
(lower band) was co-immunoprecipitated with GFP-CCAR2
from lysates of irradiated cells, in agreement with a damage-
independent interaction (Fig. 5c).
In addition, by using puriﬁed, bacterial-expressed GST
(glutathione S-transferase)-CtIP as bait, we were able to
pull-down GFP-CCAR2 from whole extracts from human cells
(Fig. 5d and Supplementary Fig. 4c). By expressing three
truncated versions of GFP-CCAR2, we mapped the interaction
region of CCAR2 and CtIP to the ﬁrst two-thirds of the protein
(Fig. 5d and Supplementary Fig. 4c).
We then performed in vitro direct binding assays using
full-length His6-CCAR2 and GST-CtIP puriﬁed from bacteria.
We detected a direct interaction between the two proteins
(Fig. 5e). Using a series of CtIP fragments, we mapped the
interaction between CtIP and CCAR2 to the C-terminal part of
CtIP (from amino acid 650 to the end of the protein), which
covers the region that mediates the interaction of CtIP and
the MRN complex (amino acids 790–897)6 (Fig. 5e,f). This
interaction between CtIP and CCAR2 was at odds with the lack of
colocalization of both proteins at laser-induced damage.
However, we reasoned that these observations could reﬂect a
general interaction of both proteins in the bulk population in
contrast to what occurs with local exclusion at damaged
chromatin (Fig. 3c). Hence, we repeated the proximity-ligation
assay in cells expressing GFP-MDC1, which is recruited to
damaged DNA. We analysed the interaction between CCAR2 and
CtIP in the vicinity of the damaged chromatin (that is, in MDC1
foci; Fig. 5g). We clearly observed that the CCAR2–CtIP PLA
signal almost never colocalized with DNA damage, in agreement
with the two proteins being recruited to laser microirradiation
mainly in a mutually exclusive manner.
Discussion
Using a unique reporter, we identiﬁed 340 genes that have a role in
maintaining the balance between NHEJ and HR in human cells.
We used very stringent conditions for the selection of positive
candidates. Thus, some proteins with a role in the DSB repair
pathway choice may be missing from our ﬁnal list (Supplementary
Data 3). In fact, several proteins that we knew to affect the SSR are
not present in this list, but nonetheless shifted the balance in the
predicted manner (see Supplementary Data 1 for details). These
include pro-recombination activities such as CtIP, BRCA1,
MRE11, BLM and EXO1 as well as NHEJ proteins such as LIG4.
Moreover, as our genomic approach does not guarantee
Figure 4 | CCAR2 inhibits CtIP-mediated resection. (a) Cells transduced with shRNAs against the indicated genes were irradiated (10Gy). One hour after
irradiation, cells were ﬁxed and immunostained as indicated in the Methods section. The number of cells that show RPA foci was scored and represented as
a percentage of the total. The graph represents the average and s.d.’s of three independent experiments. Representative images are shown at the right.
Scale bar, 20mm (b). The length of resected DNA was calculated using the SMART technique at individual DNA molecules. A Mann–Whitney test was
performed to analyse the differences in dispersion. A representative experiment is shown. The median is shown in red. (c) The median of the resected DNA
lengths was normalized to controls in cells depleted of the indicated proteins. The plot represents the average and s.d. of the normalized medians of four
independent experiments. (d) DiVA cells were treated with 4-OHT to induce translocation of the nuclease AsiSI to the nucleus or were mock-treated, as
described in the Methods section. Chromatin bound to RPA was immunoprecipitated and the occupancy of RPA was detected by qRT–PCR at 80 bp (left) or
800bp (right) of three DSBs. DSB-3 represents a chromosome break that is exclusively repaired by NHEJ, whereas both NHEJ and HR can repair DSB-III
and DSB-V. The same approach was performed in cells depleted for CCAR2 (black bars) or control cells (white bars). (e) Same as d, but using an antibody
against CtIP for ChIP. (f) SMART assay with cells expressing the indicated plasmids and transfected with siRNA against CCAR2 (black bars) or a control
sequence (siNT, white bars). Further details are as in c.
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Figure 5 | CCAR2 and CtIP interacts physically in a constitutive manner. (a) Cells depleted of the indicated genes were analysed with a PLA using CtIP
and CCAR2 antibodies. The average and s.d. of the medians of three independent experiments are plotted on the left. A representative image of each
condition is shown on the right. The top graph was obtained with cells unchallenged by exogenous damage. The plots on the bottom side were calculated in
cells 1 h after irradiation (10Gy). Scale bar, 7.5mm. (b) Protein samples from cells stably transfected with either GFP or GFP–CtIP in undamaged conditions
or 1 h after ionizing radiation (10Gy) were used for immunoprecipitation with anti-GFP resin. Immunoprecipitates were resolved in SDS–PAGE and blotted
for the indicated antibodies. The asterisk marks an unspeciﬁc band that binds to the resin, and the arrow marks the endogenous CtIP protein. (c) Same as b,
but with cells expressing GFP or GFP-CCAR2. (d) GST–CtIP was used as bait for pull-down experiments from whole-cell extracts using cells expressing GFP,
GFP-CCAR2 full-length or three deletion mutants of CCAR2, as indicated. Western blots with an anti-GFP antibody using inputs (left) and pull-downs
(right) are shown. The red arrows label the position of GFP fusions. (e) Bacterial-puriﬁed His6-CCAR2 was pulled down with bacterial-puriﬁed GST–CtIP
full-length and deletion constructs. Puriﬁed GSTwas used as a control. The red arrows represent the puriﬁed CtIP version. A western blot against CCAR2 is
shown at the bottom. (f) A schematic representation of all the deletion constructs used in e. Full-length CtIP and the interaction regions with CCAR2 and
the MRN complex are represented at the bottom. (g) PLA foci using CtIP and CCAR2 antibodies in cells expressing GFP-MDC1 that were collected 1 h after
irradiation (10Gy). Scale bar, 7.5mm.
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downregulation of all the genes in the library, we may have missed
some important factors because of insufﬁcient depletion.
Interestingly, we spotted not only genes that are required for
HR prevalence over NHEJ but also a class of factors with the
opposite role. Thus, we describe a sizeable set of genes whose
depletion caused a hyper-recombinant phenotype in human cells.
Such factors share similar functions to those required for NHEJ24,
those that decrease the stability of resection proteins, such as
PIN1 (ref. 25) or CDH1 (ref. 26) and those that block resection,
such as RIF1, 53BP1, REV7 and HELB27–30. In an approach
similar to ours but using the recombination assay DR-GFP, a
previous study found that several genes are required for gene
conversion10. We compared both screenings and found little
overlap between the two screenings. This might reﬂect the
aforementioned weaknesses of genome-wide siRNA strategies
and the stringent conditions applied to the selection of candidates
in both screenings; however, it could also be that the distinct
screening strategies targeted different steps in the recombination
pathway and thus complemented each other. The DR-GFP screen
readily responds to Rad51-dependent strand invasion, and indeed
the majority of the isolated hits corresponded to proteins that
affect Rad51 expression10. In contrast, the SSR system is
Rad51-independent and readily reacts to changes in DNA
resection8. Notably, Adamson et al.10 did not ﬁnd any genes
that showed hyper-recombination phenotypes upon depletion. In
contrast, we clearly isolated factors that favour homology-
mediated repair when downregulated (Supplementary Data 3).
Hyper-recombinant mutants have been abundantly isolated from
other organisms1 but rarely from higher eukaryotes. Thus, we
present the ﬁrst comprehensive list of genes that cause a
hyper-recombinant phenotype when depleted in human cells.
The majority of genes that affected the SSR ratio belong to the
functional categories of DNA repair, replication and recombination,
cell cycle or mRNA metabolism, indicating the relevance of such
processes in controlling DSB repair. In terms of pathogenesis,
we also found a clear correlation between DSB repair balance
and cancer.
We singled out CCAR2 to exemplify this category of genes that
have a pro-NHEJ and antirecombination role in the cell. CCAR2
interacts with BRCA1 (ref. 21), a well-known tumour suppressor
required for HR31 and to modulate the speed of DNA end
resection18. CCAR2 inhibits BRCA1’s transcriptional role21,
affects cell proliferation by controlling SIRT1 and p53
(refs 13,14,20,32) and is involved in RNA metabolism33. In
most published studies, the role of CCAR2 depends on its role as
a SIRT1 inhibitor, a function that requires the phosphorylation of
CCAR2 at threonine 454 (refs 13,14,20). However, here we
describe an SIRT1-independent function in HR. In agreement,
CCAR2 contribution to DNA repair has previously been shown
to be SIRT1-independent32,34. Despite the lack of a direct
involvement of SIRT1, this new function of CCAR2 is also
dependent on ATM-mediated phosphorylation.
The physical relationship between CCAR2 and BRCA1
suggested the possibility that BRCA1 bridges an interaction
between CtIP and CCAR2. However, we have excluded this
possibility, as this interaction (measured by PLA) was maintained
or even increased in the absence of BRCA1. Here we extend the
relationship between CCAR2 and DNA repair by showing
CCAR2’s direct physical and functionally antagonistic relation-
ship with CtIP. CCAR2 acts as a bona ﬁde inhibitor of DNA end
resection: it not only regulates which cells resect their DNA but
also limits the length of the produced resected DNA. Indeed,
depletion of CCAR2 increases the amount of CtIP recruited to
AsiSI-induced DSBs, mostly at locations further away of the
actual cleavage site. Hence, we postulate that CCAR2 might
constrain the spreading of CtIP along the DNA, thereby spatially
conﬁning resection. Interestingly, in a proteomic screen CCAR2
was found to interact with all three subunits of the RPA
complex35; hence, such an interaction might be required for this
role-limiting resection. By doing so, it affects all HR pathways,
including the most conservative gene conversion. Although it has
a mild effect in inhibiting NHEJ, as is expected when breaks are
hyper-resected, we conclude that the major role of CCAR2 in
DSB repair balance is to antagonize resection spreading. In
agreement, CCAR2 depletion does not affect the recruitment of
NHEJ proteins such as 53BP1 (ref. 34). Such a role in HR could
contribute to CCAR2 sensitivity to DSB-inducing agents32,36. Our
data are in apparent contrast to a previously published report that
proposes CCAR2 to be an enhancer of HR, using a recombination
reporter in SW480sn3 cells36. However, this might reﬂect
differences in the reporters used, and, more speciﬁcally, the
length of gene conversion tracks required to render positive
colonies. This hypothesis is supported by the fact that CCAR2 not
only affects the number of DSBs to be resected but also mainly
controls the length of DNA that will be resected, hence
modulating gene conversion tracks and crossovers37.
Mechanistically, we propose the following model (Fig. 6).
CCAR2 interacts constitutively with CtIP in a DNA damage-
independent manner in the nucleoplasm (Fig. 6i). Despite the
proximity of the CCAR2 and MRN interaction sites in CtIP, there
is no competition between the two (Supplementary Fig. 5). Thus,
it is more likely that the physical presence of CCAR2 negatively
regulates the activity of the CtIP–MRN complex. Upon the
appearance of a broken DNA molecule, CCAR2 and CtIP
recruitment depends on the cell cycle phase. In G1 cells, only
CCAR2 is recruited, as resection will be inactive4,17. In G2 and
(perhaps) S phase, however, they are probably recruited together
to chromatin, accounting for the 18% of CtIP laser line-positive
cells that also showed CCAR2 accumulation (Fig. 6 ii). The fact
that CCAR2 downregulation does not affect CtIP recruitment but
only limits its spreading along the DNA, while CtIP depletion
reduces CCAR2 exclusion, reinforces the idea that CtIP inhibition
by CCAR2 is because of the physical interaction between the two.
While the bulk of CtIP and CCAR2 in the nucleoplasm retain
their interaction upon DNA damage, the CCAR2–CtIP complex
appears to be disrupted locally on damaged chromatin (Fig. 6 iii
and iv). Remarkably, CCAR2 interacts only with the
non-phosphorylated form of CtIP. In this scenario, either one
factor or the other rapidly takes command of the situation. Which
one dominates depends on several factors, such as cell cycle
distribution or chromatin status. Indeed, CCAR2 affects the
kinetics of repair of breaks that occur in heterochromatin but not
in euchromatin34. Strikingly, CCAR2 has little effect on breaks
that are always repaired by NHEJ, but is critical for DSB repair
pathway choice for breaks that could be repaired by HR or NHEJ.
When a break will be repaired by NHEJ (Fig. 6 iii)—that is, all of
the breaks that occur in G1, and many of those in G2–CtIP exits
the damaged chromatin, but CCAR2 stays on, constraining DNA
end resection and allowing NHEJ to ensue. This retention of
CCAR2 and its role as an antagonist of resection requires ATM
activity and CCAR2 ATM-mediated phosphorylation at
threonine 454 (ref. 20). This parallels the RIF1–53BP1
antiresection pathway, which is also triggered by 53BP1
ATM-mediated phosphorylation27,28. In contrast, DSBs that
will be resected maintain CtIP at sites of DNA damage, and do
not accumulate (G2) or even actively exclude (S phase) CCAR2
from these sites (Fig. 6 iv and v), probably thereby allowing the
catalytic activity of the MRN complex. Such behaviour of CCAR2
is CtIP-dependent and allows CtIP and DNA end resection to be
activated. An interesting hypothesis is that resection will be
limited to this chromatin region devoid of CCAR2 (antistripe;
Fig. 6v), and will stop as soon as it enters a nuclear region in
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which CCAR2 is still present. This would minimize the chance of
hyper-resection of DSBs, a phenomenon that may be associated
with an increase in genomic instability37,38. The model predicts
that the extent of resection in human cells is higher in the S phase
than in the G2 phase, a phenomenon that has been observed in
budding yeasts39. This might explain the increased length of
resected DNA tracks upon CCAR2 depletion, as all S- and
G2-phase cells would resect their DNA as long as if they were in
G2. This will also suggest that HR is probably different between
S and G2 cells, as the length of resection will affect the balance
between different recombination subpathways, controlling the
size of gene conversion tracks and interfering with crossover
formations37.
We have observed that the CtIP–CCAR2 interaction is
independent of BRCA1, suggesting that all pairwise interactions
occur independently. This crosstalk between BRCA1, CtIP and
CCAR2 might then regulate the ﬁdelity of DNA repair, which
could explain why all three of these are related to the appearance
of breast cancer yet have opposite effects on HR40–42. Thus,
CCAR2 is emerging as a critical protein controlling cellular
response to stress, including DNA damage, and it elicits a very
complex response that involves many parallel reactions.
Methods
Cell culture and manipulations. Cells were cultured in high-glucose DMEM
supplemented with 10% fetal bovine serum (FBS), 2mM glutamine, 100 mgml 1
streptomycin and 100Uml 1 penicillin at 37 C in 5% CO2. Plasmids were
transfected using FugeneHD Transfection Reagent (Promega) according to the
manufacturer’s instructions. siRNAs against CCAR2 (50-GCUUAUAGUUCGA
AGGUAC-30), CtIP (50-GCUAAAACAGGAACGAAUC-30), luciferase (50-CGUA
CGCGGAAUACUUCGA-30), SIRT1 (Dharmacon SMARTpool L-003540-00) and
a control non-target sequence (a mix of 50-UGGUUUACAUGUCGACUAA-30 ,
50-UGGUUUACAUGUUGUGUGA-30, 50-UGGUUUACAUGUUUUCUGA-30
and 50-UGGUUUACAUGUUUUCCUA-30) were transfected with RNAiMax
Lipofectamine Reagent Mix (Life Technologies), according to the manufacturer’s
instructions. Lentiviruses harbouring shRNA vectors (SIGMA) targeting CtIP
(TRCN0000318738), CCAR2 (TRCN0000053723), BRCA1 (TRCN0000009823) or
a non-target sequence (SHC016V 01031212MN) were used to infect U2OS cells.
Lentiviral particles were obtained as described8. Brieﬂy, lentiviral particles were
generated by calcium phosphate transfection in A293T cells. After 48 hours,
lentiviruses were collected from the media by 100,000 g centrifugation for 2 hours
at 4 C. Cells stably expressing the shRNAs were selected by adding 1 mgml 1
puromycin to the medium after infection. U2OS were a gift from Stephen
P. Jackson. FUCCI-U2OS cells were obtained by stably transfecting U2OS cells
with pFucci-G1 Orange (AM-V9003) and pFucci-S/G2 Green (AM-V9010) from
Amalgaam.
esiRNA human whole-genome screening. All manipulations were performed
using a Hamilton Microlab STAR robot (301–3,811) following a protocol designed
by the Genomic Unit of CABIMER. The screening was carried out using the MIS-
SION esiRNA library (SIGMA) targeting 16,538 human genes based on sequence
annotation from the ENSEMBL database. The esiRNAs were aliquoted (30 nM) in a
96-well plate format, with each plate harbouring an esiRNA against luciferase as a
control. U2OS-SSR2.0 cells were then reverse-transfected at 6,000 cells per well using
RNAiMax Lipofectamine Reagent Mix (Life Technologies), according to the
manufacturer’s instructions. After 6 h, media was replaced to minimize cell death.
At 36 h after transfection, I-SceI–BFP (blue ﬂuorescent protein) lentivirus
(multiplicity-of-infection of 10) and 6mgml 1 polybrene diluted in DMEM were
added to the cells. Cells were washed the next day with new media; after another
24 h, cells were washed with PBS, ﬁxed with 4% paraformaldehyde and washed twice
with PBS. Before staining with Hoechst 33,342, a representative picture was taken to
calculate the efﬁciency of the I-SceI–BFP infection. Plates were then imaged using an
ImageXpress Micro (Molecular Devices) at  10 magniﬁcation, and pictures were
taken at nine sites (ﬁelds) per well. Nuclei, GFP and RFP signals were detected with
blue, green and Texas Red ﬁlters, respectively. Images were analysed, and the amount
of GFP- and RFP-positive cells were quantiﬁed automatically with the Image
MetaExpress Software (Molecular Devices). The ratio of GFP:RFP cells in each well
was normalized using the internal control with esiLUC (Supplementary Data 1).
Plasmids. GFP-CtIP was published elsewhere7. Full-length CCAR2 cDNA was
inserted into the pET28a expression vector (Novagen) to add a polyhistidine (His6)
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Figure 6 | Schematic depiction of the effect of CCAR2 on DNA end resection. CtIP and CCAR2 interact constitutively. Upon the appearance of DSBs, they
are both recruited (ii), but soon only one of them is left remaining at the breaks (iii and iv). DSB repaired by NHEJ maintains CCAR2 in an ATM-dependent
manner, facilitating repair (iii). In contrast, DSBs that require DNA end resection maintain only CtIP at the break, and, indeed, CCAR2 is completely
excluded from the region in a CtIP and/or DNA end resection manner (iv). This allows resection to progress until it covers the CCAR2-free region (v).
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tag at the N terminus of CCAR2 protein. The cDNA was also cloned into
pEGFP-C1 to create the full-length GFP-CCAR2 construct and mutated to avoid
silencing with the siRNA. The GFP-CCAR2-T454A mutant was obtained by
mutagenesis. CCAR2 deletion mutants were obtained from the full-length
construct by cleavage with ApaI and ligation of the obtained fragments in
pEGFP-C1 linearized with ApaI (1–185 fragment) or EcoRI-ApaI (187–606 and
608–924 fragments). The full-length pGEX-CtIP construct and CtIP fragment
constructs and GFP-MDC1 were a kind gift from Steve Jackson (University of
Cambridge, UK).
Gene conversion:NHEJ and NHEJ:HR balance analysis. U2OS cells bearing a
single-copy integration of the reporters DR-GFP (Gene conversion)11, EJ5-GFP
(NHEJ)12 or SSR (NHEJ:HR)8 were used to analyse the different DSB repair
pathways. In all cases, 4,000 cells were plated in 96-well plates. One day after
seeding, cells were transfected with the indicated siRNA or infected with lentiviral
particles carrying the indicated shRNA. The medium was changed after 6–8 h. The
following day, cells were infected with a lentivirus harbouring I-SceI and labelled
with BFP43 at an multiplicity-of-infection of 10. After 24 h, cells were washed with
fresh medium and maintained during an additional 24 h. Cells were then ﬁxed with
4% paraformaldehyde, stained with Hoechst 33,432 and washed with PBS before
visualization with a ﬂuorescent microscope for blue, green and, in the case of SSR,
red ﬂuorescence, as described in the previous section. The repair frequency was
calculated as the percentage of blue cells expressing GFP for the DR-GFP and
EJ5-GFP. For the NHEJ:HR balance, the ratio between green versus red cells in
each conditions was calculated as published8. To facilitate the comparison between
experiments, this ratio was normalized with siRNA or an shRNA control.
Conditions that skewed the balance towards increased NHEJ repair resulted in a
fold increase above 1. In contrast, a net decrease of this ratio (for example, values
below 1) represented an imbalance of SSR towards HR. Data represent a minimum
of four sets of triplicate experiments.
In silico analysis. Candidate gene sets were analysed using the IPA Software
(Ingenuity Systems, www.ingenuity.com) available through PAB (The Andalusian
Platform of Bioinformatics, www.scbi.uma.es) from the University of Malaga.
A total of 330 ID genes of 340 candidates were recognized and analysed using the
Ingenuity Knowledge database. The core analysis tool was used to visualize
functional categories’ enrichment and associated networks. Fisher’s exact test
right-tailed was performed using the IPA Software to calculate P values using a
cutoff of 0.05.
Cell cycle analysis using ﬂow cytometer. Cells were harvested, washed with PBS
and resuspended in ice-cold PBS. EtOH (70%) was added dropwise while vortexing
at low speed, and cells were then ﬁxed at 4 C for at least 2 h. Cells were washed
with PBS and treated with 250mgml 1 RNase A (SIGMA) and 10mgml 1
propidium iodide diluted in PBS (Fluka). Cells were incubated at 37 C for 30min
and analysed using a FACSCalibur (BD).
Immunoﬂuorescence microscopy. U2OS cells were infected with lentivirus
harbouring the indicated shRNA or a control sequence. After 48 h, cells were
irradiated (10Gy) or mock-treated, incubated 1 h for foci formation and collected.
For the experiment with inhibitors, ATMi (10 mM), ATRi (5mM) or PARPi (1 mM)
was added to the plates 30min before irradiation. For RPA foci formation, cov-
erslips were treated for 5min on ice with pre-extraction buffer (25mM Tris-HCl,
pH 7.5, 50mM NaCl, 1mM EDTA, 3mM MgCl2, 300mM sucrose and 0.2%
Triton X-100), and then ﬁxed with 4% paraformaldehyde (w/v) in PBS for 15min.
For CCAR2 foci, cells were ﬁxed with 4% paraformaldehyde (w/v) in PBS for
15min on ice, washed twice with PBS and permeabilized with 0.2% Triton X-100
(v/v) in PBS for 10min on ice. Then, coverslips were washed three times with
PBS and blocked for at least 1 h with 5% FBS diluted in PBS. Cells were
incubated with the adequate primary antibodies (Supplementary Table 2), diluted
in 5% FBS in PBS for 2 h at room temperature, washed with PBS and then
incubated with secondary antibodies (Supplementary Table 3) diluted in 5% FBS in
PBS for 1 h at room temperature. Cells were then washed twice with PBS, and
coverslips were mounted with Vectashield mounting medium (Vector
Laboratories) containing DAPI and analysed using a LEICA microscope. At least
200 cells were scored per sample. Experiments were repeated independently at least
three times.
Laser microirradiation. For laser microirradiation, cells with the indicated
downregulated proteins were grown in medium containing 10 mM bromodeox-
yuridine (BrdU, GE Healthcare) for 24 h in glass-bottom dishes or on coverslips.
Pretreatment with inhibitors was performed as described in the previous section.
A Zeiss PALM Microbeam microscope was used to induce DNA damage with a
UV-A (355 nm) laser. Experiments of microirradiated cells were performed in
CO2-independent, phenol red–free DMEM. Laser output was set to the lowest
setting that induced DNA damage, as monitored by phosphorylation of H2AX.
Confocal images were obtained with a Leica Microscope TCS 5PS, using the LAS
AF Software (Leica). The MetaMorph Software was used to quantify the amount of
ﬂuorescence (stripes and antistripes) across a linear pathway transversal to the
microirradiated signal, visualized as gH2AX. At least 200 cells positive for gH2AX
stripes were counted per sample.
Proximity-ligation assay. PLAs were performed using the Duolink PLA Kit
(Olink Bioscience, Uppsala, Sweden) according to the manufacturer’s protocol.
Brieﬂy, U2OS cells were infected with lentivirus harbouring the indicated shRNA
or a control sequence. After selection in medium with 1 mgml 1 puromycin
during 3 days, cells were treated with ionizing radiation (10Gy) or mock-treated,
incubated 1 h and then collected. Coverslips were washed with PBS, ﬁxed on ice
with methanol for 10min followed by acetone for 30 s, washed three times with
PBS and blocked with blocking solution from the Duolink PLA Kit for 30min at
37 C. Samples were incubated with primary antibodies against CCAR2 and CtIP
(Supplementary Table 2) overnight at 4 C, followed by MINUS and PLUS
secondary PLA probes (antimouse minus and antirabbit plus) for 1 h at 37 C.
Detection was carried out with the Duolink Detection Kit Red (Olink Bioscience).
At least 200 cells were analysed using a Leica Fluorescence microscope and foci
counted automatically using command Granularity of the MetaMorph software.
Immunoblotting. Extracts were prepared in Laemmli buffer (4% SDS, 20% gly-
cerol and 125mM Tris-HCl, pH 6.8), and proteins were resolved using SDS–PAGE
and transferred to PVDF-LF membranes (Millipore), followed by immunoblotting.
Western blot analysis was carried out using the antibodies listed in Supplementary
Tables 2 and 3. Results were visualized using an Odyssey Infrared Imaging
System (Li-Cor). Uncropped images of the most important blots are shown in
Supplementary Figures.
Single-molecule analysis of resection tracks. SMART was performed as
described18. Brieﬂy, U2OS cells downregulated for the indicated genes were grown
in the presence of 10mM BrdU for 24 h. Cultures were then irradiated (10Gy) and
harvested after 1 h. Cells were embedded in low-melting agarose (Bio-Rad),
followed by DNA extraction. To stretch the DNA ﬁbres, silanized coverslips
(Genomic Vision) were dipped into the DNA solution for 15min and pulled out at
a constant speed (250 mms 1). Coverslips were baked for 2 h at 65 C and
incubated directly without denaturation with an anti-BrdU mouse monoclonal
antibody (Supplementary Table 2). After washing with PBS, coverslips were
incubated with the secondary antibody (Supplementary Table 3). Finally, coverslips
were mounted with ProLong Gold Antifade Reagent (Molecular Probes) and stored
at  20 C. DNA ﬁbres were observed with a Nikon NI-E microscope and a PLAN
FLOUR 40 0.75 PHL DLL objective. The images were recorded and processed
with the NIS ELEMENTS Nikon Software. For each experiment, at least 200 DNA
ﬁbres were analysed, and the length of DNA ﬁbres was measured with Adobe
Photoshop CS4 Extended version 11.0 (Adobe Systems Incorporated).
Protein expression and puriﬁcation. Recombinant proteins were expressed in
Escherichia coli BL21 (DE3). A fresh single transformant colony was inoculated
into 5ml of LB medium containing kanamycin (30mgml 1) for His6-CCAR2, or
ampicillin (50 mgml 1) for pGEX-CtIP constructs, and the cultures were
incubated at 37 C overnight with shaking. A 2.5ml aliquot of the overnight culture
was inoculated into 250ml of LB medium containing the appropriate antibiotic
and incubated at 23 C (for His6-CCAR2) or 30 C (for GST-CtIP constructs), until
A600 reached 0.7. Expression was induced by adding isopropyl-1-thio-D-galacto-
pyranoside (IPTG, Duchefa Biochimie). The ﬁnal concentration of IPTG was 1mM
for CCAR2 and 0.1mM for CtIP fragments. At 3 h after induction, cells were
collected by centrifugation at 13,000g for 30min, and the bacterial pellets were
frozen immediately at  80 C. For His6-CCAR2, the stored pellet was thawed and
resuspended in sonication buffer (20mM Tris-HCl, pH 8, 500mM NaCl, 20%
glycerol, 15mM b-mercaptoethanol and 1% Tween-20). For CtIP fragment
puriﬁcation, the pellets were thawed and resuspended in PBS. Cells were disrupted
by sonication, and the lysate was clariﬁed by centrifugation. For His6-CCAR2
puriﬁcation, supernatant was loaded onto a Ni2þ -sepharose column (His-Trap HP
columns, GE Healthcare) that had been pre-equilibrated with sonication buffer
(SB). The column was washed with 10ml of SB supplemented with 60mM imi-
dazole, eluted with a 30ml gradient of imidazole (at 60mM to 1M) in SB and then
collected in 0.5ml fractions. For CtIP puriﬁcation, the supernatant was loaded on a
GSTrap HP column (GE Healthcare) pre-equilibrated with PBS. The columns were
washed with PBS and eluted with 50mM Tris-HCl, pH 8 and 10mM reduced
glutathione.
An aliquot of each fraction from the puriﬁcations was analysed by SDS–PAGE,
and those containing the overexpressed protein were pooled and dialysed against
either dialysis buffer 1 (50mM Tris-HCl, pH 8.0, 500mM NaCl, 1mM
dithiothreitol and 50% glycerol) for CCAR2, or dialysis buffer 2 (PBS, 30%
glycerol) for CtIP and its deletion fragments. The protein preparation was divided
into aliquots and stored at  80 C. Protein concentrations were determined by the
Bradford assay, and denatured proteins were analysed by SDS–PAGE.
Pull-down assay using puriﬁed proteins. Eighty pmol of puriﬁed GST alone,
GST-CtIP or GST fused to CtIP fragments were resuspended in a ﬁnal volume of
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300ml with PBS, mixed with 100ml of pre-equilibrated glutathione sepharose 4b resin
(GE Healthcare) and incubated for 1 h at 4 C. The resin was washed twice with
binding buffer (20mM Tris, pH 7.5, 1mM EDTA, 10mM beta-mercaptoethanol,
0.5% Triton and 50mM NaCl). One hundred pmol of puriﬁed His6-CCAR2 was
incubated at 4 C for 1 h with either GST or GST-tagged proteins bound to resin.
The matrix was washed twice with wash buffer (binding buffer with 3mM reduced
glutathione). Bound proteins were separated by SDS–PAGE (7.5%), transferred to
polyvinylidene diﬂuoride (PVDF) membranes and analysed by western blot analysis
using antibodies against CCAR2.
Pull-down assay from whole-cell extracts. Protein extracts from cells transfected
with the different versions of GFP-CCAR2 were prepared in lysis buffer (20mM
Tris, pH 7.5, 1mM EDTA, 0.5% Triton, 50mM NaCl, 1 protease inhibitors
(Roche) and 1 phosphatase inhibitor cocktail 1 (Sigma)). The amount of
expression of each CCAR2 fragment was calculated by western blotting. Similar
amounts of each CCAR2 truncated version were used for pull-down assays. After
adding beta-mercaptoethanol (ﬁnal concentration 10mM) to the samples, cell
extracts were pre-cleared by incubating with 50 ml of pre-equilibrated glutathione
sepharose 4B resin (GE Healthcare) for 1 h at 4 C.
Eighty pmol of puriﬁed GST-CtIP were resuspended in a ﬁnal volume of 500 ml
with PBS, mixed with 100 ml of pre-equilibrated glutathione sepharose 4B resin and
incubated for 1 h at 4 C. The resin was washed twice with binding buffer (lysis
buffer with 10mM beta-mercaptoethanol but without protease and phosphatase
inhibitors) and then incubated with the pre-cleared cell extracts for 2 h at 4 C. The
matrix was washed twice with wash buffer (binding buffer with 3mM reduced
glutathione), and proteins were eluted by boiling the slurry for 5min in protein-
loading buffer. Precipitated proteins were separated by SDS–PAGE, transferred to
PVDF membranes and analysed by western blot analysis.
Immunoprecipitation. U2OS cells overexpressing GFP, GFP-CtIP or GFP-CCAR2
were irradiated (10Gy) or mock-treated and harvested 1 h later in lysis buffer
(50mM Tris-HCl pH 7.5, 50mM NaCl, 0.2% Triton X-100, 1 protease inhibitors
(Roche) and 1 phosphatase inhibitor cocktail 1 (Sigma)). Protein extract
(900 mg) was mixed with 30ml of pre-equilibrated magnetic anti-GFP resin
(GFP-Trap_M, Chromotek) and incubated overnight at 4 C by gently rocking.
Beads were then washed three times with lysis buffer, and the precipitate was eluted
in 40ml of Laemmli buffer.
Chromatin immunoprecipitation. ChIP assays were carried out essentially as
described44. Brieﬂy, DiVA cells harbouring the nuclease AsiSI fused to the
oestrogen receptor were incubated for 4 h with 300 nM of tamoxifen (4-OHT) to
induce the translocation of the nuclease to the nucleus and the induction of DSBs.
Cells expressing shRNA against CCAR2 or shRNA non-target were used as a
control. Chromatin (300 mg) was immunoprecipitated with 2 mg of anti-RPA,
anti-CtIP and anti-IgG (mock; Supplementary Table 2). The enrichment of speciﬁc
DNA loci was analysed in immunoprecipitated chromatin and the input in
triplicates by quantitative reverse transcriptase PCR (qRT–PCR). Primers are listed
in Supplementary Table 4.
Statistical analysis. Statistical signiﬁcance was determined with a paired Student’s t-
test using the PRISM software (Graphpad Software Inc.). Statistically signiﬁcant dif-
ferences were labelled with one, two or three asterisks if Po0.05, Po0.01 or Po0.001,
respectively. A Mann–Whitney test was used to detect statistically signiﬁcant differ-
ences between the populations of resected DNA ends detected by SMART.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the article (and its Supplementary Information ﬁles) and
upon request.
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